Pages that link to "Q38107833"

The following pages link to HMGA2 and high-grade serous ovarian carcinoma (Q38107833):

Displaying 31 items.

• The Fragment HMGA2-sh-3p20 from HMGA2 mRNA 3'UTR Promotes the Growth of Hepatoma Cells by Upregulating HMGA2. (Q33704649) (← links)
• Anti-miR182 reduces ovarian cancer burden, invasion, and metastasis: an in vivo study in orthotopic xenografts of nude mice (Q33895739) (← links)
• STC2 overexpression mediated by HMGA2 is a biomarker for aggressiveness of high-grade serous ovarian cancer. (Q34484508) (← links)
• Detection of high mobility group A2 specific mRNA in the plasma of patients affected by epithelial ovarian cancer (Q36326396) (← links)
• miR-33-5p, a novel mechano-sensitive microRNA promotes osteoblast differentiation by targeting Hmga2. (Q36691156) (← links)
• Overexpression and oncogenic function of HMGA2 in endometrial serous carcinogenesis (Q36878690) (← links)
• A novel truncated form of HMGA2 in tumors of the ovaries (Q37106836) (← links)
• Collecting duct carcinoma of the kidney is associated with CDKN2A deletion and SLC family gene up-regulation. (Q37327370) (← links)
• Role of Nerve Growth Factor (NGF) and miRNAs in Epithelial Ovarian Cancer (Q37729033) (← links)
• HMGA proteins as modulators of chromatin structure during transcriptional activation. (Q38264460) (← links)
• Transcriptional activation of FN1 and IL11 by HMGA2 promotes the malignant behavior of colorectal cancer. (Q38787288) (← links)
• RKIP inhibits gastric cancer cell survival and invasion by regulating the expression of HMGA2 and OPN. (Q38961655) (← links)
• HMGA2 is associated with epithelial-mesenchymal transition and can predict poor prognosis in nasopharyngeal carcinoma (Q41816648) (← links)
• Genetic variations in monocyte chemoattractant protein-1 and susceptibility to ovarian cancer. (Q46026383) (← links)
• Nanoscale Assembly of High-Mobility Group AT-Hook 2 Protein with DNA Replication Fork. (Q47270675) (← links)
• Bivalent Epigenetic Control of Oncofetal Gene Expression in Cancer (Q47295917) (← links)
• HMGA2 facilitates epithelial-mesenchymal transition in renal cell carcinoma by regulating the TGF-β/Smad2 signaling pathway (Q47401110) (← links)
• The long noncoding RNA HULC promotes liver cancer by increasing the expression of the HMGA2 oncogene via sequestration of the microRNA-186. (Q48002616) (← links)
• High mobility group protein A2 overexpression indicates poor prognosis for cancer patients: a meta-analysis (Q49288145) (← links)
• Potential microRNA-related Targets for Therapeutic Intervention with Ovarian Cancer Metastasis (Q49593669) (← links)
• Tumor suppressive role of miR-569 in lung cancer. (Q55096022) (← links)
• HMGA2 gene silencing reduces epithelial-mesenchymal transition and lymph node metastasis in cervical cancer through inhibiting the ATR/Chk1 signaling pathway (Q58733935) (← links)
• MiR-219-5p inhibits growth and metastasis of ovarian cancer cells by targeting HMGA2 (Q59811983) (← links)
• Cytological Immunostaining of HMGA2, LRP1B, and TP63 as Potential Biomarkers for Triaging Human Papillomavirus-Positive Women (Q64053906) (← links)
• Comparative analysis of AKT and the related biomarkers in uterine leiomyomas with MED12, HMGA2, and FH mutations (Q88780844) (← links)
• Oncofetal HMGA2 attenuates genotoxic damage induced by topoisomerase II target compounds through the regulation of local DNA topology (Q91604246) (← links)
• Long noncoding RNA VPS9D1-AS1 augments the malignant phenotype of non-small cell lung cancer by sponging microRNA-532-3p and thereby enhancing HMGA2 expression (Q92422285) (← links)
• High mobility group AT-hook 2 and c-MYC as potential prognostic factors in pancreatic ductal adenocarcinoma (Q92835478) (← links)
• Integrative genomics approach identifies molecular features associated with early-stage ovarian carcinoma histotypes (Q94686779) (← links)
• Gene Fusions Characterize a Subset of Uterine Cellular Leiomyomas (Q97543940) (← links)
• Emerging roles for HMGA2 in colorectal cancer (Q100696903) (← links)